Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-087897
Filing Date
2025-06-18
Accepted
2025-06-18 16:15:07
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3698
  Complete submission text file 0000950170-25-087897.txt   5141
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RAPPORT THERAPEUTICS 1325 BOYLSTON ST., SUITE 401 BOSTON MA 02215
Business Address
Bredt David (Reporting) CIK: 0002022087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42121 | Film No.: 251057132